Compared with that in theNGT group, the IRAK-M level was significantly decreased in PD-A, PD-B, or T2Dgroups, whereas the TXNIP level was significantly increased in these threegroups (all p < 0.05, Figure 1a and 1b). The gene discussed is TXNIP; the disease is Patent ductus arteriosus.